author_facet Jaglowski, Samantha M.
Ruppert, Amy S.
Heerema, Nyla A.
Bingman, Anissa
Flynn, Joseph M.
Grever, Michael R.
Jones, Jeffrey A.
Elder, Patrick
Devine, Steven M.
Byrd, John C.
Andritsos, Leslie A.
Jaglowski, Samantha M.
Ruppert, Amy S.
Heerema, Nyla A.
Bingman, Anissa
Flynn, Joseph M.
Grever, Michael R.
Jones, Jeffrey A.
Elder, Patrick
Devine, Steven M.
Byrd, John C.
Andritsos, Leslie A.
author Jaglowski, Samantha M.
Ruppert, Amy S.
Heerema, Nyla A.
Bingman, Anissa
Flynn, Joseph M.
Grever, Michael R.
Jones, Jeffrey A.
Elder, Patrick
Devine, Steven M.
Byrd, John C.
Andritsos, Leslie A.
spellingShingle Jaglowski, Samantha M.
Ruppert, Amy S.
Heerema, Nyla A.
Bingman, Anissa
Flynn, Joseph M.
Grever, Michael R.
Jones, Jeffrey A.
Elder, Patrick
Devine, Steven M.
Byrd, John C.
Andritsos, Leslie A.
British Journal of Haematology
Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
Hematology
author_sort jaglowski, samantha m.
spelling Jaglowski, Samantha M. Ruppert, Amy S. Heerema, Nyla A. Bingman, Anissa Flynn, Joseph M. Grever, Michael R. Jones, Jeffrey A. Elder, Patrick Devine, Steven M. Byrd, John C. Andritsos, Leslie A. 0007-1048 1365-2141 Wiley Hematology http://dx.doi.org/10.1111/j.1365-2141.2012.09239.x <jats:title>Summary</jats:title><jats:p>Complex karyotype (<jats:styled-content style="fixed-case">CK</jats:styled-content>) on metaphase cytogenetics discriminates poor outcome in chronic lymphocytic leukaemia (<jats:styled-content style="fixed-case">CLL</jats:styled-content>) patients undergoing salvage treatment; we hypothesized that it might provide prognostic information for patients undergoing allogeneic stem cell transplant. Fifty‐one <jats:styled-content style="fixed-case">CLL</jats:styled-content> patients were analysed following transplant; 18‐month overall survival (<jats:styled-content style="fixed-case">OS</jats:styled-content>), event‐free survival (<jats:styled-content style="fixed-case">EFS</jats:styled-content>) and cumulative incidence of progression estimates were 35%, 14% and 63%, respectively, in patients with <jats:styled-content style="fixed-case">CK</jats:styled-content> (<jats:italic>n</jats:italic> = 19) versus 83%, 68% and 29% in patients without (<jats:italic>n</jats:italic> = 32) (<jats:italic>P </jats:italic>≤ 0·0001, <jats:italic>P </jats:italic>≤ 0·0001, and <jats:italic>P</jats:italic> = 0·02). In patients with high‐risk interphase cytogenetics, <jats:styled-content style="fixed-case">CK</jats:styled-content> remained predictive of worse <jats:styled-content style="fixed-case">OS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·02) and <jats:styled-content style="fixed-case">EFS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·009). These findings support further evaluation of metaphase karyotype in transplant risk assessment.</jats:p> Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia British Journal of Haematology
doi_str_mv 10.1111/j.1365-2141.2012.09239.x
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjE0MS4yMDEyLjA5MjM5Lng
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjE0MS4yMDEyLjA5MjM5Lng
institution DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
imprint Wiley, 2012
imprint_str_mv Wiley, 2012
issn 0007-1048
1365-2141
issn_str_mv 0007-1048
1365-2141
language English
mega_collection Wiley (CrossRef)
match_str jaglowski2012complexkaryotypepredictsforinferioroutcomesfollowingreducedintensityconditioningallogeneictransplantforchroniclymphocyticleukaemia
publishDateSort 2012
publisher Wiley
recordtype ai
record_format ai
series British Journal of Haematology
source_id 49
title Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
title_unstemmed Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
title_full Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
title_fullStr Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
title_full_unstemmed Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
title_short Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
title_sort complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
topic Hematology
url http://dx.doi.org/10.1111/j.1365-2141.2012.09239.x
publishDate 2012
physical 82-87
description <jats:title>Summary</jats:title><jats:p>Complex karyotype (<jats:styled-content style="fixed-case">CK</jats:styled-content>) on metaphase cytogenetics discriminates poor outcome in chronic lymphocytic leukaemia (<jats:styled-content style="fixed-case">CLL</jats:styled-content>) patients undergoing salvage treatment; we hypothesized that it might provide prognostic information for patients undergoing allogeneic stem cell transplant. Fifty‐one <jats:styled-content style="fixed-case">CLL</jats:styled-content> patients were analysed following transplant; 18‐month overall survival (<jats:styled-content style="fixed-case">OS</jats:styled-content>), event‐free survival (<jats:styled-content style="fixed-case">EFS</jats:styled-content>) and cumulative incidence of progression estimates were 35%, 14% and 63%, respectively, in patients with <jats:styled-content style="fixed-case">CK</jats:styled-content> (<jats:italic>n</jats:italic> = 19) versus 83%, 68% and 29% in patients without (<jats:italic>n</jats:italic> = 32) (<jats:italic>P </jats:italic>≤ 0·0001, <jats:italic>P </jats:italic>≤ 0·0001, and <jats:italic>P</jats:italic> = 0·02). In patients with high‐risk interphase cytogenetics, <jats:styled-content style="fixed-case">CK</jats:styled-content> remained predictive of worse <jats:styled-content style="fixed-case">OS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·02) and <jats:styled-content style="fixed-case">EFS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·009). These findings support further evaluation of metaphase karyotype in transplant risk assessment.</jats:p>
container_issue 1
container_start_page 82
container_title British Journal of Haematology
container_volume 159
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792341500955197440
geogr_code not assigned
last_indexed 2024-03-01T16:20:54.78Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Complex+karyotype+predicts+for+inferior+outcomes+following+reduced%E2%80%90intensity+conditioning+allogeneic+transplant+for+chronic+lymphocytic+leukaemia&rft.date=2012-10-01&genre=article&issn=1365-2141&volume=159&issue=1&spage=82&epage=87&pages=82-87&jtitle=British+Journal+of+Haematology&atitle=Complex+karyotype+predicts+for+inferior+outcomes+following+reduced%E2%80%90intensity+conditioning+allogeneic+transplant+for+chronic+lymphocytic+leukaemia&aulast=Andritsos&aufirst=Leslie+A.&rft_id=info%3Adoi%2F10.1111%2Fj.1365-2141.2012.09239.x&rft.language%5B0%5D=eng
SOLR
_version_ 1792341500955197440
author Jaglowski, Samantha M., Ruppert, Amy S., Heerema, Nyla A., Bingman, Anissa, Flynn, Joseph M., Grever, Michael R., Jones, Jeffrey A., Elder, Patrick, Devine, Steven M., Byrd, John C., Andritsos, Leslie A.
author_facet Jaglowski, Samantha M., Ruppert, Amy S., Heerema, Nyla A., Bingman, Anissa, Flynn, Joseph M., Grever, Michael R., Jones, Jeffrey A., Elder, Patrick, Devine, Steven M., Byrd, John C., Andritsos, Leslie A., Jaglowski, Samantha M., Ruppert, Amy S., Heerema, Nyla A., Bingman, Anissa, Flynn, Joseph M., Grever, Michael R., Jones, Jeffrey A., Elder, Patrick, Devine, Steven M., Byrd, John C., Andritsos, Leslie A.
author_sort jaglowski, samantha m.
container_issue 1
container_start_page 82
container_title British Journal of Haematology
container_volume 159
description <jats:title>Summary</jats:title><jats:p>Complex karyotype (<jats:styled-content style="fixed-case">CK</jats:styled-content>) on metaphase cytogenetics discriminates poor outcome in chronic lymphocytic leukaemia (<jats:styled-content style="fixed-case">CLL</jats:styled-content>) patients undergoing salvage treatment; we hypothesized that it might provide prognostic information for patients undergoing allogeneic stem cell transplant. Fifty‐one <jats:styled-content style="fixed-case">CLL</jats:styled-content> patients were analysed following transplant; 18‐month overall survival (<jats:styled-content style="fixed-case">OS</jats:styled-content>), event‐free survival (<jats:styled-content style="fixed-case">EFS</jats:styled-content>) and cumulative incidence of progression estimates were 35%, 14% and 63%, respectively, in patients with <jats:styled-content style="fixed-case">CK</jats:styled-content> (<jats:italic>n</jats:italic> = 19) versus 83%, 68% and 29% in patients without (<jats:italic>n</jats:italic> = 32) (<jats:italic>P </jats:italic>≤ 0·0001, <jats:italic>P </jats:italic>≤ 0·0001, and <jats:italic>P</jats:italic> = 0·02). In patients with high‐risk interphase cytogenetics, <jats:styled-content style="fixed-case">CK</jats:styled-content> remained predictive of worse <jats:styled-content style="fixed-case">OS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·02) and <jats:styled-content style="fixed-case">EFS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·009). These findings support further evaluation of metaphase karyotype in transplant risk assessment.</jats:p>
doi_str_mv 10.1111/j.1365-2141.2012.09239.x
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjE0MS4yMDEyLjA5MjM5Lng
imprint Wiley, 2012
imprint_str_mv Wiley, 2012
institution DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275
issn 0007-1048, 1365-2141
issn_str_mv 0007-1048, 1365-2141
language English
last_indexed 2024-03-01T16:20:54.78Z
match_str jaglowski2012complexkaryotypepredictsforinferioroutcomesfollowingreducedintensityconditioningallogeneictransplantforchroniclymphocyticleukaemia
mega_collection Wiley (CrossRef)
physical 82-87
publishDate 2012
publishDateSort 2012
publisher Wiley
record_format ai
recordtype ai
series British Journal of Haematology
source_id 49
spelling Jaglowski, Samantha M. Ruppert, Amy S. Heerema, Nyla A. Bingman, Anissa Flynn, Joseph M. Grever, Michael R. Jones, Jeffrey A. Elder, Patrick Devine, Steven M. Byrd, John C. Andritsos, Leslie A. 0007-1048 1365-2141 Wiley Hematology http://dx.doi.org/10.1111/j.1365-2141.2012.09239.x <jats:title>Summary</jats:title><jats:p>Complex karyotype (<jats:styled-content style="fixed-case">CK</jats:styled-content>) on metaphase cytogenetics discriminates poor outcome in chronic lymphocytic leukaemia (<jats:styled-content style="fixed-case">CLL</jats:styled-content>) patients undergoing salvage treatment; we hypothesized that it might provide prognostic information for patients undergoing allogeneic stem cell transplant. Fifty‐one <jats:styled-content style="fixed-case">CLL</jats:styled-content> patients were analysed following transplant; 18‐month overall survival (<jats:styled-content style="fixed-case">OS</jats:styled-content>), event‐free survival (<jats:styled-content style="fixed-case">EFS</jats:styled-content>) and cumulative incidence of progression estimates were 35%, 14% and 63%, respectively, in patients with <jats:styled-content style="fixed-case">CK</jats:styled-content> (<jats:italic>n</jats:italic> = 19) versus 83%, 68% and 29% in patients without (<jats:italic>n</jats:italic> = 32) (<jats:italic>P </jats:italic>≤ 0·0001, <jats:italic>P </jats:italic>≤ 0·0001, and <jats:italic>P</jats:italic> = 0·02). In patients with high‐risk interphase cytogenetics, <jats:styled-content style="fixed-case">CK</jats:styled-content> remained predictive of worse <jats:styled-content style="fixed-case">OS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·02) and <jats:styled-content style="fixed-case">EFS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·009). These findings support further evaluation of metaphase karyotype in transplant risk assessment.</jats:p> Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia British Journal of Haematology
spellingShingle Jaglowski, Samantha M., Ruppert, Amy S., Heerema, Nyla A., Bingman, Anissa, Flynn, Joseph M., Grever, Michael R., Jones, Jeffrey A., Elder, Patrick, Devine, Steven M., Byrd, John C., Andritsos, Leslie A., British Journal of Haematology, Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia, Hematology
title Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
title_full Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
title_fullStr Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
title_full_unstemmed Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
title_short Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
title_sort complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
title_unstemmed Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
topic Hematology
url http://dx.doi.org/10.1111/j.1365-2141.2012.09239.x